联合雾化吸入对慢性阻塞性肺疾病急性加重期治疗的临床观察

来源 :中国实用医药 | 被引量 : 0次 | 上传用户:wtxsing
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的探讨联合雾化吸入对慢性阻塞性肺疾病急性加重期的临床效果。方法选取本院2013年收治的41例慢性阻塞性肺部疾病急性加重期患者,随机分为对照组(20例)和治疗组(21例),治疗组采取布地奈德和硫酸特布他林雾化液雾化吸入治疗,对照组采取常规治疗,治疗2周后,观察两组患者的临床疗效、pH值、PaCO2、PO2。结果两组患者经治疗,治疗前后PaCO2、PO2、pH值明显改善,P<0.05表示差异具有统计学意义。两组间差异比较,P>0.05表示差异无统计学意义。结论联合雾化吸入治疗慢性阻塞性肺疾病急性加重期,疗效显著,能够明显改善患者肺部功能,缓解临床症状,具有较高的临床价值。 Objective To investigate the clinical effect of combined inhalation on acute exacerbation of chronic obstructive pulmonary disease. Methods Forty-one patients with acute exacerbation of chronic obstructive pulmonary disease admitted to our hospital in 2013 were randomly divided into control group (n = 20) and treatment group (n = 21). The treatment group received budesonide and terbutaline sulfate Atomization inhalation treatment, the control group to take conventional treatment, after 2 weeks of treatment, the clinical efficacy of two groups were observed, pH, PaCO2, PO2. Results After treatment, the PaCO2, PO2 and pH values ​​of the two groups were significantly improved before and after treatment, P <0.05 indicated the difference was statistically significant. Differences between the two groups, P> 0.05 showed no significant difference. Conclusion The combination of inhalation of inhalation for the treatment of chronic obstructive pulmonary disease in acute exacerbation period has significant curative effect, which can significantly improve pulmonary function and relieve clinical symptoms of patients with high clinical value.
其他文献
期刊
目的:探索运用中西医结合方法治疗慢性胃炎的临床疗效。方法选取经纤维内镜及活检确诊的57例慢性胃炎患者,其中采用中西药结合治疗的36例为治疗组,仅用枸橼酸铋钾口服治疗的21例
期刊
期刊
期刊
“特别报道”栏目倾注了编辑、记者最多的心血和汗水.每每完成一期专题的制作,编辑们总会有些新的感悟和思考.借用“编辑手记”,愿与大家分享.也欢迎大家在微博上与我们互动:
期刊
期刊
期刊
上海金仕达卫宁股份有限公司是一家以医疗卫生领域应用软件的研究开发、销售和技术服务为主,并为医疗卫生行业信息化提供整体解决方案的软件企业,已成功在创业板上市,是医疗
期刊
期刊